With €65 billion lost each year to stroke and dementia in Germany, nyra health secures €20 million to scale digital neurotherapy

Introduction:

Neurological diseases such as stroke, dementia, and traumatic brain injury cause a staggering €65 billion in costs annually in Germany alone. This immense burden on the healthcare system is due in part to the lack of effective and accessible rehabilitation options for those affected. However, Vienna-based startup nyra health is on a mission to change that. With the completion of a €20 million Series A financing round, nyra health is set to revolutionize the field of neurorehabilitation with its AI-based platform. This funding will allow the company to expand its technology platform in the DACH region, accelerate its growth in the US, and establish a new standard for data-driven neurorehabilitation.

Key Takeaways:

• Nyra health, a Vienna-based startup, has secured €20 million in Series A funding to scale its AI-based platform for neurological therapy.
• This funding will allow the company to expand its technology platform in the DACH region, accelerate its growth in the US, and establish a new standard for data-driven neurorehabilitation.
• This round of financing was led by Armira Growth, with participation from existing investors such as Wellington Partners, Crane Venture Partners, and EVER Pharma.
• This funding aligns with a broader trend of investment in neurological and HealthTech innovation across Europe, with over €60 million in funding raised by companies focused on neurological diseases and digital care solutions.
• Nyra health's AI platform, myReha, is currently used in over 100 rehabilitation clinics and has the support of over 28 health insurance companies.
• The company's goal is to make neurological therapy widely accessible and effective for all those affected, regardless of their location or healthcare system.
• Nyra health's technology has been shown to significantly increase therapy time while also delivering cost savings. This has led to automatic reimbursements from 28 statutory and private health insurance companies, giving over 40 million insured individuals access to the platform.
• The company is also investing in the technological advancement of its platform, including the development of multimodal AI models for therapeutic interaction and diagnostics.
• Nyra health is expanding its reach by connecting with additional clinic groups in the DACH region and preparing to enter the US market.
• The company is also working on a funded research project worth €4.2 million, in collaboration with leading US research universities, to further validate and improve its technology.

Nyra health's mission is to provide effective, individualized care for those affected by neurological diseases, regardless of their location or healthcare system. With the support of €20 million in funding, the company is well on its way to achieving this goal and making a significant impact on the healthcare industry. The convergence of technology and neurological care through companies like nyra health is a promising sign for the future of healthcare, with the potential to improve the lives of millions of people affected by these debilitating diseases.

Source: https://www.eu-startups.com/2026/02/with-e65-billion-lost-each-year-to-stroke-and-dementia-in-germany-nyra-health-secures-e20-million-to-scale-digital-neurotherapy/